CLDN3 and cholangiocarcinoma: Proteins in the bile EV of 20 patients with benign and malignant gallbladder diseases were determined by Proteomics analysis, in order to evaluate the expression of CLDN3, showing that CLDN3 is a candidate diagnosis of CCA with an AUC of 94.5% [175].